Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study
Hamish Innes, Scott McDonald, Victoria Hamill, Alan Yeung, John Dillon, Peter Hayes, April Went, Andrew Fraser, Andrew Bathgate, Stephen Barclay, Naveed Janjua, David Goldberg, Sharon Hutchinson
The impact of interferon (IFN)-free therapies on the epidemiology of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) is not well understood at a population level. Our goal was to bridge this evidence gap.